EUVIMEDEUVIMED entdecken
Vergleichsstudie

Hemigland cryoablation versus high-intensity focused ultrasound for localized prostate cancer: a propensity-weighted comparison of functional and oncologic outcomes

Umberto Anceschi, Salvatore Basile, Leonardo Misuraca, Riccardo Mastroianni, Simone D'Annunzio, Flavia Proietti, Alfredo Maria Bove, Francesco Prata, Riccardo Capecchi, Giuseppe Spadaro, Mariaconsiglia Ferriero, Franco Lugnani und 1 weitere

World Journal of Urology · 26.03.2026 · 44 (1)

DOI: 10.1007/s00345-026-06378-1 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift World Journal of Urology, online erschienen am 26.03.2026. Verfasst von Umberto Anceschi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Uro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. umberto.anceschi…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Cryosurgery, High-Intensity Focused Ultrasound Ablation, Ultrasound, High-Intensity Focused, Transrectal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Whether cryoablation and high-intensity focused ultrasound (HIFU) provide distinct advantages in hemigland ablation for localized prostate cancer (PCa) is unresolved. METHODS: A prospective FT-PCa registry (2021–2025) was analysed, identifying 258 men treated with hemigland ablation (cryoablation n = 179; HIFU n = 79). Baseline differences were addressed through inverse-probability-of-treatment weighting based on age, PSA, PSA density, ISUP, PI-RADS, lesion size, % of positive cores and prostate volume. Weighted Kaplan–Meier estimators, log-rank tests and Cox models were used for time-to-event outcomes; perioperative and functional variables were compared using design-based t-tests and Rao–Scott χ² tests. Primary endpoints were failure-free survival (FFS) and biochemical failure-free survival (BFS). A subgroup analysis excluding low-risk disease was additionally performed. RESULTS: Weighting achieved excellent covariate balance (all standardized mean differences 0.7) were comparable. IPSS scores showed no significant difference after weighting (p = 0.54). At 24 months, FFS (89.3% vs. 87.8%; weighted log-rank p = 0.66) and BFS (87.9% vs. 85.6%; weighted log-rank p = 0.79) showed no significant differences, and Cox models revealed no independent hazard signal. Cancer-specific, metastasis-free and overall survival each exceeded 95% (all p > 0.7). Findings were unchanged after excluding low-risk patients. CONCLUSIONS: In this propensity-weighted comparison of hemigland FT, cryoablation and HIFU yielded comparable outcomes. When case-mix is balanced, energy modality exerts minimal influence on short-term cancer control or functional recovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsCryosurgeryHigh-Intensity Focused Ultrasound AblationUltrasound, High-Intensity Focused, TransrectalHumansMaleTreatment OutcomeAgedPropensity ScoreProspective StudiesMiddle Aged

Stichwörter der Autor:innen

cryoablationfunctional outcomeshemigland focal therapyhigh-intensity focused ultrasoundlocalized prostate canceroncologic outcomespropensity score weighting

Autor:innen und Institutionen

  • Uro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. umberto.anceschi@gmail.com.
  • Uro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. salvatore.basile91@gmail.com.
  • Uro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.

Zitieren

APA

Anceschi, U., Basile, S., Misuraca, L., Mastroianni, R., D'Annunzio, S., Proietti, F., Bove, A. M., Prata, F., Capecchi, R., Spadaro, G., Ferriero, M., Lugnani, F., & Simone, G. (2026). Hemigland cryoablation versus high-intensity focused ultrasound for localized prostate cancer: a propensity-weighted comparison of functional and oncologic outcomes. World Journal of Urology, 44(1). https://doi.org/10.1007/s00345-026-06378-1

Vancouver

Anceschi U, Basile S, Misuraca L, Mastroianni R, D'Annunzio S, Proietti F, et al. Hemigland cryoablation versus high-intensity focused ultrasound for localized prostate cancer: a propensity-weighted comparison of functional and oncologic outcomes. World Journal of Urology. 2026;44(1). doi:10.1007/s00345-026-06378-1

BibTeX
@article{Anceschi2026,
  author = {Anceschi, Umberto and Basile, Salvatore and Misuraca, Leonardo and Mastroianni, Riccardo and D'Annunzio, Simone and Proietti, Flavia and Bove, Alfredo Maria and Prata, Francesco and Capecchi, Riccardo and Spadaro, Giuseppe and Ferriero, Mariaconsiglia and Lugnani, Franco and Simone, Giuseppe},
  title = {Hemigland cryoablation versus high-intensity focused ultrasound for localized prostate cancer: a propensity-weighted comparison of functional and oncologic outcomes},
  journal = {World Journal of Urology},
  year = {2026},
  volume = {44},
  number = {1},
  doi = {10.1007/s00345-026-06378-1}
}
Kostenlos starten →